Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
Authors
Keywords
Systemic JIA, Refractory disease, Translational research, Lung disease, Macrophage activation syndrome
Journal
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-21
DOI
10.1016/j.rdc.2021.06.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of anti-inflammatory drugs in children with asthma
- (2021) Fernando Maria de Benedictis et al. Current Opinion in Allergy and Clinical Immunology
- Ruxolitinib‐combined doxorubicin‐etoposide‐methylprednisolone regimen as a salvage therapy for refractory/relapsed haemophagocytic lymphohistiocytosis: a single‐arm, multicentre, phase 2 trial
- (2021) Jingshi Wang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
- (2021) Anne B. Chang et al. EUROPEAN RESPIRATORY JOURNAL
- Sudden Hypotension and Increased Serum IFN-γ and IL-10 Predict Early Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis Patients
- (2021) Li Guo et al. JOURNAL OF PEDIATRICS
- Efficacy of moderately dosed etoposide in macrophage activation syndrome - hemophagocytic lymphohistiocytosis (MAS-HLH)
- (2021) AnnaCarin Horne et al. JOURNAL OF RHEUMATOLOGY
- Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
- (2021) Nicolino Ruperto et al. RHEUMATOLOGY
- Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
- (2021) Camille Keenan et al. Frontiers in Immunology
- Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
- (2020) Brigitte Bader-Meunier et al. ANNALS OF THE RHEUMATIC DISEASES
- Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
- (2020) Qiongyi Hu et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2020) Masaki Shimizu et al. Pediatric Rheumatology
- Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
- (2020) Jessica Vandenhaute et al. Frontiers in Immunology
- Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease
- (2020) Satoshi Sato et al. ANNALS OF THE RHEUMATIC DISEASES
- Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy
- (2020) Georgia Griffin et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- The genetics of macrophage activation syndrome
- (2020) Grant S. Schulert et al. GENES AND IMMUNITY
- Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
- (2020) Franco Locatelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy
- (2020) Hitoshi Irabu et al. PEDIATRIC RESEARCH
- Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience
- (2020) Amieleena Chhabra et al. RHEUMATOLOGY
- Tofacitinib-induced remission in refractory adult-onset Still’s disease complicated by macrophage activation syndrome
- (2020) M Honda et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation
- (2020) Lauren K. Meyer et al. BLOOD
- Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
- (2020) Scott W. Canna et al. Pediatric Rheumatology
- New medications are needed for children with juvenile idiopathic arthritis
- (2020) Hermine I Brunner et al. Arthritis & Rheumatology
- Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still’s disease: case report and review of the literature
- (2020) Jihad Ben Gabr et al. Annals of Translational Medicine
- Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis
- (2020) Bruce C. Trapnell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding of cytokines and targeted therapy in macrophage activation syndrome
- (2020) Shunli Tang et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort
- (2019) Mia Glerup et al. ARTHRITIS CARE & RESEARCH
- Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline
- (2019) Don Hayes et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis
- (2019) Faekah Gohar et al. ANNALS OF THE RHEUMATIC DISEASES
- Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis
- (2019) Zhixiang Huang et al. PEDIATRICS
- Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients
- (2019) Joost F Swart et al. RHEUMATOLOGY
- IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome
- (2019) Shima Yasin et al. RHEUMATOLOGY
- Emergent high fatality lung disease in systemic juvenile arthritis
- (2019) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis
- (2019) Mounica Vallurupalli et al. BLOOD
- Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
- (2019) Esraa M. Eloseily et al. Arthritis & Rheumatology
- Synergistic TLR/IFNα/β-Signaling Facilitates Escape of IL-18 Expression from Endotoxin Tolerance
- (2019) Emely Verweyen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2019) Maiko Takakura et al. CLINICAL IMMUNOLOGY
- Cystic Fibrosis Lung Disease: An Overview
- (2019) Nelson L Turcios Respiratory Care
- Anakinra in children and adults with Still’s disease
- (2019) Sebastiaan J Vastert et al. RHEUMATOLOGY
- Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China
- (2019) Li-Xia Zou et al. World Journal of Pediatrics
- Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management
- (2019) Lauren A. Henderson et al. PEDIATRIC DRUGS
- Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors
- (2019) Grant S. Schulert et al. Arthritis & Rheumatology
- Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
- (2019) Adriana A. de Jesus et al. JOURNAL OF CLINICAL INVESTIGATION
- Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
- (2018) Eric S. Weiss et al. BLOOD
- Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature
- (2018) Hafize Emine Sönmez et al. CLINICAL RHEUMATOLOGY
- Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
- (2018) Naoto Sakumura et al. CYTOKINE
- The 14th International Workshops on Opportunistic Protists (IWOP 14)
- (2018) Melanie T. Cushion et al. JOURNAL OF EUKARYOTIC MICROBIOLOGY
- Systemic Juvenile Idiopathic Arthritis
- (2018) Jennifer J.Y. Lee et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis
- (2018) Grant S. Schulert et al. ARTHRITIS CARE & RESEARCH
- Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
- (2018) Alberto Martini et al. JOURNAL OF RHEUMATOLOGY
- Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis
- (2018) Maiko Takakura et al. PEDIATRICS INTERNATIONAL
- Treatment of refractory adult onset Still’s disease with combination anakinra and baricitinib therapy
- (2018) Chayma Ladhari et al. RHEUMATOLOGY
- Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs
- (2018) Gabriela Schmajuk et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
- (2018) S. A. Kerrigan et al. Current Rheumatology Reports
- Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition
- (2017) Scott W. Canna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
- (2017) Nicolino Ruperto et al. Pediatric Rheumatology
- Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis
- (2017) Christoph Kessel et al. Arthritis & Rheumatology
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2016) Claudia Bracaglia et al. ANNALS OF THE RHEUMATIC DISEASES
- Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis
- (2016) R. Das et al. BLOOD
- Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice
- (2016) Sophia Maschalidi et al. BLOOD
- Macrophage activation syndrome in the era of biologic therapy
- (2016) Alexei A. Grom et al. Nature Reviews Rheumatology
- Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus
- (2016) Selin Aytaç et al. RHEUMATOLOGY INTERNATIONAL
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat
- (2016) Angelo Ravelli et al. Arthritis & Rheumatology
- Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
- (2015) Grant S. Schulert et al. Annual Review of Medicine
- Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis
- (2015) Masaki Shimizu et al. CLINICAL IMMUNOLOGY
- Macrophage Activation Syndrome
- (2015) Angelo Ravelli et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza
- (2015) Grant S. Schulert et al. JOURNAL OF INFECTIOUS DISEASES
- Dissecting the Heterogeneity of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
- (2015) F. Minoia et al. JOURNAL OF RHEUMATOLOGY
- Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
- (2015) S. Yokota et al. JOURNAL OF RHEUMATOLOGY
- Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis
- (2015) Peter A. Nigrovic PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
- (2015) Karen Put et al. RHEUMATOLOGY
- Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis
- (2015) Xiao Hu et al. World Journal of Pediatrics
- IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vγ6+γδ T cells
- (2015) Aoi Akitsu et al. Nature Communications
- Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
- (2015) Alexei A. Grom et al. Arthritis & Rheumatology
- Azithromycin and the Treatment of Lymphocytic Airway Inflammation After Lung Transplantation
- (2014) R. Vos et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis
- (2014) Sebastiaan Vastert et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
- (2014) Scott W Canna et al. NATURE GENETICS
- Genetic Defects in Cytolysis in Macrophage Activation Syndrome
- (2014) Mingce Zhang et al. Current Rheumatology Reports
- Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
- (2014) Francesca Minoia et al. Arthritis & Rheumatology
- Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
- (2014) Kenneth M. Kaufman et al. Arthritis & Rheumatology
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- An Official American Thoracic Society Clinical Practice Guideline: Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy
- (2013) Geoffrey Kurland et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis
- (2013) A. Tambralli et al. JOURNAL OF RHEUMATOLOGY
- Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis
- (2013) Colleen K. Correll et al. PEDIATRIC RESEARCH
- Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study
- (2013) Sebastiaan J. Vastert et al. Arthritis & Rheumatology
- Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
- (2012) A Ravelli et al. GENES AND IMMUNITY
- Diagnostic Accuracy of a Specific Cytokine Pattern in Hemophagocytic Lymphohistiocytosis in Children
- (2012) Xiao-Jun Xu et al. JOURNAL OF PEDIATRICS
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis
- (2012) Esi Morgan DeWitt et al. ARTHRITIS CARE & RESEARCH
- Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
- (2012) Yukiko Kimura et al. ARTHRITIS CARE & RESEARCH
- Understanding TLR9 action in Epstein-Barr virus infection
- (2011) Ludwig Zauner Frontiers in Bioscience-Landmark
- Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice
- (2011) Edward M. Behrens et al. JOURNAL OF CLINICAL INVESTIGATION
- Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
- (2011) J. L. RECORD et al. JOURNAL OF RHEUMATOLOGY
- Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
- (2011) Elizabeth D. Mellins et al. Nature Reviews Rheumatology
- Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
- (2010) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
- (2010) P. M. Miettunen et al. RHEUMATOLOGY
- Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy
- (2010) Tomomi Aizawa-Yashiro et al. RHEUMATOLOGY INTERNATIONAL
- Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis
- (2009) Wilco de Jager et al. ARTHRITIS AND RHEUMATISM
- Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
- (2009) R. A.G. RUSSO et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
- (2009) G. Horneff et al. RHEUMATOLOGY
- Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
- (2009) Sebastiaan J. Vastert et al. RHEUMATOLOGY
- Hemophagocytic lymphohistiocytosis (HLH) and related disorders
- (2009) A. H. Filipovich Hematology-American Society of Hematology Education Program
- Mutations of the hemophagocytic lymphohistiocytosis–associated geneUNC13D in a patient with systemic juvenile idiopathic arthritis
- (2008) Melissa M. Hazen et al. ARTHRITIS AND RHEUMATISM
- The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
- (2008) Marco Gattorno et al. ARTHRITIS AND RHEUMATISM
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms
- (2008) Kejian Zhang et al. ARTHRITIS AND RHEUMATISM
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More